Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IDYA
IDYA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IDYA News
IDEAYA Biosciences to Participate in Investor Events
Feb 02 2026
PRnewswire
IDEAYA Biosciences to Participate in Investor Events
Feb 02 2026
Newsfilter
IDEAYA Grants 44,200 Stock Options to New Employee
Jan 30 2026
PRnewswire
IDEAYA Grants 44,200 Stock Options to New Employee
Jan 30 2026
Newsfilter
IDEAYA Biosciences Updates 2026 Corporate Objectives at J.P. Morgan Conference
Jan 11 2026
PRnewswire
IDEAYA Biosciences Updates 2026 Strategic Objectives, Plans to Advance Four Registrational Trials
Jan 11 2026
Newsfilter
IDEAYA Biosciences Outlines 2026 Corporate Objectives and Clinical Progress
Jan 11 2026
Yahoo Finance
IDYA Options Offer Attractive Discounts and Yield Boosts
Jan 06 2026
NASDAQ.COM
IDEAYA to Participate in 44th Annual J.P. Morgan Healthcare Conference
Jan 05 2026
PRnewswire
IDEAYA Biosciences Options Volume Surges to 9,708 Contracts
Dec 30 2025
NASDAQ.COM
Novo Nordisk (NVO) Gains 9.48% After FDA Approves Wegovy Obesity Pill
Dec 23 2025
NASDAQ.COM
IDEAYA Achieves Complete Enrollment in Key Trial of Darovasertib for Metastatic Uveal Melanoma
Dec 11 2025
NASDAQ.COM
IDEAYA Completes Enrollment of 435 Patients for Darovasertib Trial in Metastatic Uveal Melanoma
Dec 11 2025
PRnewswire
IDEAYA Completes Enrollment of 435 Patients for Darovasertib Trial, Supporting Approval Filing
Dec 11 2025
Newsfilter
IDEAYA Submits IND Application for IDE574, Plans Phase 1 Trial in Q1 2026
Dec 10 2025
PRnewswire
IDEAYA Submits IND Application, Phase 1 Trial of IDE574 Expected in Q1 2026
Dec 10 2025
Newsfilter
Show More News
